3
Announcements
Trials
Browse
Landscape
Phase
Phase NA
1
Status
Recruiting
1
Sponsor Class
OTHER
1
Study Type
Interventional
1
Sponsor
Cancer Type
Endocrine
1
CNS
1
Conditions
Brain Neoplasms
12
Cognitive Dysfunction
4
Radiation Injuries
3
Neoplasms
3
Multiple Myeloma
3
Glioma
3
Lymphoma, B-Cell
2
Lymphoma
2
Glioblastoma
2
Fatigue
2
Breast Neoplasms
2
Astrocytoma
2
Triple Negative Breast Neoplasms
1
Stroke
1
Sarcoma
1
Pituitary Neoplasms
1
Parkinson Disease
1
Osteosarcoma
1
Oligodendroglioma
1
Neurotoxicity Syndromes
1
Neurofibromatosis 1
1
Neoplasm Metastasis
1
Meningioma
1
Lymphoma, Non-Hodgkin
1
Lymphoma, Large B-Cell, Diffuse
1
Lymphoma, B-Cell, Marginal Zone
1
Lung Neoplasms
1
Localized, Operable Non-small Cell Lung Cancer
1
Liver Neoplasms
1
Liver Diseases
1
Interventions
Magnetic Resonance Spectroscopy
12
gallium Ga 68 dotatate
6
Everolimus
6
lutetium Lu 177 dotatate
5
Radiosurgery
5
Proton Therapy
5
Bevacizumab
5
pembrolizumab
4
Surveys and Questionnaires
4
Specimen Handling
4
Hydroxyurea
4
abemaciclib
3
Tranexamic Acid
3
Surgical Procedures, Operative
3
Sodium Chloride
3
Ga(III)-DOTATOC
3
2-phenyl-6-(2'-(4'-(ethoxycarbonyl)thiazolyl))thiazolo(3,2-b)(1,2,4)triazole
3
vistusertib
2
trametinib
2
ribociclib
2
arginyllysine
2
aldesleukin
2
Yoga
2
Whole Body Imaging
2
Sunitinib
2
Saline Solution
2
Ropivacaine
2
Radiotherapy
2
Protons
2
Observation
2
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
OTHER
×
Meningioma
×
Neuropsychological Tests
×
Clear all
NCT05727605
2024-05-08
NARCiS
Universitaire Ziekenhuizen KU Leuven
Phase NA
Recruiting
120 enrolled